Real World Evidence To Expand Knowledge of CDK4/6 Inhibitor-Related Adverse Effects
Host: Christopher M. Gallagher, MD
\n\n Host: Adam Brufsky, MD, PhD
\n\n\n \n
This program focuses on increasing clinician familiarity and comfort with real-world evidence (RWE) of CDK4/6 inhibitors in metastatic breast cancer (MBC) and clinicians\u2019 confidence in their ability to discuss RWE with their patients.